我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
37
7 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
1907
进行中(未招募)
2
5.4%
已完成
22
59.5%
Enrolling By Invitation
1
2.7%
尚未招募
4
10.8%
招募中
5
13.5%
Unknown
撤回
暂无批准数据
- ONWARD Medical enrolled the first participant in Empower BP, a global pivotal study evaluating the ARC-IM System for blood pressure instability after spinal cord injury. - Blood pressure instability affects 78% of individuals with tetraplegia, yet only 28% receive treatment, representing a significant unmet medical need. - Previous clinical feasibility studies published in Nature Medicine showed immediate blood pressure increases and reduced hypotensive symptoms lasting up to two years. - The randomized, double-blinded, sham-controlled study will involve approximately 20 centers across the US, Canada, and Europe.